首页> 外文OA文献 >Efficacy and safety of tacrolimus ointment monotherapy in Chinese patients with moderate to severe atopic dermatitis

【2h】

Efficacy and safety of tacrolimus ointment monotherapy in Chinese patients with moderate to severe atopic dermatitis

机译：他克莫司软膏单药治疗中重度特应性皮炎的疗效和安全性

页面导航

摘要
著录项
相似文献
相关主题

摘要

published_or_final_version

机译：已发布或最终版本

著录项

作者
Yeung CK; Ma KC; Chan HHL;
展开▼
作者单位

展开▼
年度 2003
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. Evaluation of the efficacy, safety and tolerability of Tacrolimus ointment in Indian patients of moderate to severe atopic dermatitis: a multicentric, open label, phase III study. [J] . Saple DG, Torsekar RG, Pawanarkar V, Indian journal of dermatology, venereology and leprology . 2003,第6期

机译：他克莫司软膏在印度中度至重度特应性皮炎患者中的疗效，安全性和耐受性评估：一项多中心，开放标签的III期研究。
2. Efficacy of tacrolimus 0.03% ointment as second-line treatment for children with moderate-to-severe atopic dermatitis: Evidence from a randomized, double-blind non-inferiority trial vs. fluticasone 0.005% ointment [J] . DossN., KamounM.-R., DubertretL., Pediatric allergy and immunology: official publication of the European Society of Pediatric Allergy and Immunology . 2010,第2aPta1期

机译：他克莫司油膏0.03％作为中度至重度特应性皮炎患儿的二线治疗的有效性：来自一项随机，双盲，非劣效性试验的证据，与氟替卡松0.005％的药膏相比
3. Pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adult and pediatric patients with moderate to severe atopic dermatitis. [J] . Krueger GG, Eichenfield L, Goodman JJ, Journal of drugs in dermatology: JDD . 2007,第2期

机译：他克莫司软膏在中度至重度特应性皮炎的成人和儿童患者中局部应用他克莫司软膏后的他克莫司药代动力学。
4. Tacrolimus Entrapped Lipid Nanoparticles for Improved Safety and Enhanced Targeting to Deeper Skin Layers for Treatment of Atopic Dermatitis [C] . Pallavi V. Pople, Kamalinder K. Singh Annual meeting exposition of the Controlled Release Society . 2011

机译：他克莫司截留的脂质纳米颗粒可改善安全性并增强靶向深层皮肤层的治疗特应性皮炎的能力
5. Genetic determinants of Staphylococcus aureus colonization in Atopic Dermatitis patients. [D] . Yeung, Melinda K. 2008

机译：特应性皮炎患者中金黄色葡萄球菌定植的遗传决定因素。
6. Efficacy and Safety of Tralokinumab Monotherapy in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from Two 52-Week, Phase 3 Trials (ECZTRA 1 and ECZTRA 2) [O] . Eric Simpson, Andrew Blauvelt, Emma Guttman-Yassky, 2020

机译：特拉内洛替尼布单药治疗成人患者中度至重度的特征性皮炎的疗效和安全性：结果来自2阶段3阶段试验（eCZTRA 1和ECZTRA 2）

Efficacy and safety of tacrolimus ointment monotherapy in Chinese patients with moderate to severe atopic dermatitis

摘要

著录项

相似文献

相关主题

期刊订阅